Haloperidol
- Generic Name
- Haloperidol
- Brand Names
- Haldol
- Drug Type
- Small Molecule
- Chemical Formula
- C21H23ClFNO2
- CAS Number
- 52-86-8
- Unique Ingredient Identifier
- J6292F8L3D
- Background
Haloperidol is a high potency first-generation (typical) antipsychotic and one of the most frequently used antipsychotic medications used worldwide. While haloperidol has demonstrated pharmacologic activity at a number of receptors in the brain, it exerts its antipsychotic effect through its strong antagonism of the dopamine receptor (mainly D2), particularl...
- Indication
Haloperidol is indicated for a number of conditions including for the treatment of schizophrenia, for the manifestations of psychotic disorders, for the control of tics and vocal utterances of Tourette’s Disorder in children and adults, for treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted ...
- Associated Conditions
- Aggression, Delirium, Gilles de la Tourette's Syndrome, Huntington's Disease (HD), Nausea and vomiting, Obsessive Compulsive Disorder (OCD), Psychosis, Schizophrenia, Severe Disruptive Behaviour Disorders, Severe Hyperactivity
- Associated Therapies
- -
Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
- Conditions
- Interventions
- First Posted Date
- 2015-01-22
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 3
- Registration Number
- NCT02343575
- Locations
- 🇺🇸
Stanford Hospital and Clinics, Stanford, California, United States
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
- Conditions
- Interventions
- Drug: OlanzapineDrug: AmisulprideDrug: RisperidoneDrug: HaloperidolDrug: QuetiapineDrug: PerphenazineDrug: SulpirideDrug: bromperidolDrug: ZuclopenthixolDrug: ThioridazineDrug: PaliperidoneDrug: ZiprasidoneDrug: BenperidolDrug: FluspirileneDrug: PimozideDrug: PerazineDrug: FluphenazineDrug: FlupentixoleDrug: Sertindole
- First Posted Date
- 2014-12-04
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- Technical University of Munich
- Target Recruit Count
- 21
- Registration Number
- NCT02307396
- Locations
- 🇩🇪
Psychiatrische Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen Universitaet Muenchen am Klinikum rechts der Isar, Munich, Bavaria, Germany
Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia
- Conditions
- Interventions
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2017-02-16
- Lead Sponsor
- Federal Neuro-Psychiatric Hospital, Yaba
- Target Recruit Count
- 100
- Registration Number
- NCT02240173
- Locations
- 🇳🇬
Federal Neuro-Psychiatric Hospital Yaba - Lagos, Lagos, Nigeria
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
- Conditions
- Interventions
- First Posted Date
- 2014-08-12
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- Indiana University
- Target Recruit Count
- 135
- Registration Number
- NCT02213900
- Locations
- 🇺🇸
University Hospital, Indianapolis, Indiana, United States
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
- Conditions
- Interventions
- First Posted Date
- 2014-07-30
- Last Posted Date
- 2016-04-25
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 60
- Registration Number
- NCT02203786
- Locations
- 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Lurasidone Effects on Tissue Glutamate in Schizophrenia
- Conditions
- Interventions
- First Posted Date
- 2014-07-24
- Last Posted Date
- 2021-03-01
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 35
- Registration Number
- NCT02199743
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Ketamine Versus Haloperidol for Severe Agitation Outside the Hospital
- First Posted Date
- 2014-04-04
- Last Posted Date
- 2017-07-24
- Lead Sponsor
- Hennepin Healthcare Research Institute
- Registration Number
- NCT02103881
Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial
- Conditions
- Interventions
- First Posted Date
- 2014-03-28
- Last Posted Date
- 2014-03-28
- Lead Sponsor
- United States Naval Medical Center, Portsmouth
- Target Recruit Count
- 68
- Registration Number
- NCT02098499
- Locations
- 🇺🇸
Naval Medical Center Portsmouth, Portsmouth, Virginia, United States
Haloperidol vs Conventional Therapy for Gastroparesis
- First Posted Date
- 2014-02-07
- Last Posted Date
- 2017-08-17
- Target Recruit Count
- 36
- Registration Number
- NCT02057549
- Locations
- 🇺🇸
Lyndon Baines Johnson General Hospital, Houston, Texas, United States
Drug Interactions With Risk of QT-prolongation in a General Hospital
- First Posted Date
- 2014-01-23
- Last Posted Date
- 2014-06-11
- Lead Sponsor
- KU Leuven
- Target Recruit Count
- 222
- Registration Number
- NCT02043912
- Locations
- 🇧🇪
Universitair Ziekenhuis Leuven, Leuven, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.